In the presentaion today professor Trent Munro confirmed that the first in vitro screening results for autoimmune diseases in partnership with Ginko Bioworks have been received and will be reported to market this month ( sometime over next 10 days ).
Interesting that the first FDA approved Rebiotix faecal donor derived enema product relies on actual donors as does the next to be FDA approved Seres faecal donor derived ORAL capsule drug product which makes them very problematical. Microba's future products will be replicating the applicable microbiome as lab manufactured which makes it hugely more scalable and more accurately targeted.
- Forums
- ASX - By Stock
- MAP
- Ann: NWR Virtual Healthcare Conference Presentation
Ann: NWR Virtual Healthcare Conference Presentation, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MAP (ASX) to my watchlist
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $85.09M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 18.5¢ | $93.65K | 493.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 872 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 91683 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 872 | 0.185 |
1 | 855 | 0.175 |
3 | 165817 | 0.170 |
1 | 49380 | 0.165 |
3 | 15400 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 91683 | 1 |
0.195 | 222980 | 2 |
0.200 | 137925 | 3 |
0.205 | 60000 | 1 |
0.210 | 65000 | 2 |
Last trade - 15.42pm 23/08/2024 (20 minute delay) ? |
MAP (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online